Exelixis, Inc. (NASDAQ:EXEL) was less active in the last trading session as around 1.4 million shares exchanged hands on Wall Street, representing a decrease from its normal capacity of 3.29 million shares. A 0.3% change after the initial price of $30.1, sent the closing price to $30.08.Exelixis, Inc. (EXEL) Analyst Opinion
Exelixis, Inc. has a consensus outperform rating from 10 Wall Street analysts, and the number of shares currently sold short amount to at least 6.35% of shares outstanding. The stock spiked 13.85% last month and is down -1.05 this year. Wall Street is only getting more bullish on the stock, with 6 of analysts who cover EXEL having a buy-equivalent rating. Analysts have placed a $33.71 price target on Exelixis, Inc., suggesting a 12.07% gain from recent close. It’s currently trading about -7.45% below its 52-week high.
Exelixis, Inc. (EXEL) revenue totaled $104.89 million up 5.94% from the previous quarter.Exelixis, Inc. (NASDAQ:EXEL) Intraday View
This stock (EXEL) is ahead of its 52-week low with 79.9%. Its last month’s stock price volatility remained 3.7% which for the week stands at 3.49%. The share price has moved forward from its 20 days moving average, trading at a distance of 3.36% and stays 9.92% away from its 50 days moving average. Over the last five days, shares have faced -5.68% losses and now is up 20.64% since hitting its 200-day moving average of $26.74. Exelixis, Inc. (EXEL) has made its way to a 12-month gain of 65%.
Turning to Abercrombie & Fitch Co. (NYSE:ANF), its shares were trading at $19.08 a gain of $0.8, on the trading floor. The stock, after opening at $18.5, touched a high of $19.22 before paring much of its gains. So far, analysts are sticking with their bearish recommendations with the consensus call at 3.1. Abercrombie & Fitch Co. has 2 buy ratings, 9 holds and 3 sells even after the stock tumbled -0.16% from its high of $19.11 to a $1.29 billion market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 3.29 to 3.29 during a month. Analysts set a 12-month price target of $14.46 a share. The target implies a -24.21% decrease from where the shares are currently trading. Also, the current price highlights a discount of 31.03% to analysts’ high consensus price target.
The counter witnessed a trading volume of 2.31 million shares versus an average volume of 2.83 million shares during last trading session. Its last month’s stock price volatility remained 4.89% which for the week approaches 4.46%. The lowest price the stock reached in the last trading day was $18.14 and compares with the $8.81 52-week low. The stock recovered 116.57% since its low point and has performed 9.47% year-to-date.